The government has moved the Supreme Court to impose a ban on 344 fixed dose drugs, an order that was set aside by the Delhi High Court.
The Delhi HC set aside a government notification on the issue which called for a ban on 344 fixed dose drugs citing health hazards of using them.
The Health Ministry had asked for the cessation of manufacturing and sale of such drugs. The ban would have taken popular drugs like Corex cough syrup, Vicks Action 500 extra and several anti-diabetes medication off the shelves.
The Delhi HC set aside the order after allowing 454 petitions moved by various pharma and healthcare majors like Pfizer, Glenmark, Procter and Gamble and Cipla.
According to a report by The Times of India, “a bench headed by Justice Dipak Misra said the matter would be taken up after four weeks.”
While the Delhi HC had said that the Ministry had failed to get the inputs of agencies like the Drug Technical Advisory Board and Drugs Consultative Committee for the ban, the government said since the action was in favour of public health safety, it didn’t require any consultation with any authority, according to the report.
The shares of domestic pharmaceutical companies were trading in the red. Sun Pharma was down 0,23%, Aurobindo Pharma down 0.62%, Lupin Pharmaceuticals down 0.17%, Pfizer down 0.46%.